Company Overview
Hesperos Inc. provides insights into potential new drug candidates at the preclinical stage before they go into clinical trials, by recreating the functional aspect of human organs on multi-organ microchips. This new technology is helping pharmaceutical researchers, large and small, make more informed decisions on which drugs to move forward with, ultimately bringing patients new therapeutics cheaper and quicker than ever possible before. The mission of Hesperos is to revolutionize toxicology testing as well as efficacy evaluation for drug discovery. In pursuit of this mission, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational modeling of live physiological responses of functional neurons, cardiac, muscle, and neuromuscular junctions as well as liver, pancreas and barrier tissues.